These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 28906279)
1. The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. Hyle EP; Jani IV; Rosettie KL; Wood R; Osher B; Resch S; Pei PP; Maggiore P; Freedberg KA; Peter T; Parker RA; Walensky RP AIDS; 2017 Sep; 31(15):2135-2145. PubMed ID: 28906279 [TBL] [Abstract][Full Text] [Related]
2. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis. Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800 [TBL] [Abstract][Full Text] [Related]
3. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP; Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084 [TBL] [Abstract][Full Text] [Related]
4. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. Kahn JG; Marseille E; Moore D; Bunnell R; Were W; Degerman R; Tappero JW; Ekwaru P; Kaharuza F; Mermin J BMJ; 2011 Nov; 343():d6884. PubMed ID: 22074713 [TBL] [Abstract][Full Text] [Related]
5. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies. Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study. Sharma M; Mudimu E; Simeon K; Bershteyn A; Dorward J; Violette LR; Akullian A; Abdool Karim SS; Celum C; Garrett N; Drain PK Lancet HIV; 2021 Apr; 8(4):e216-e224. PubMed ID: 33347810 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. Estill J; Egger M; Blaser N; Vizcaya LS; Garone D; Wood R; Campbell J; Hallett TB; Keiser O; AIDS; 2013 Jun; 27(9):1483-92. PubMed ID: 23462219 [TBL] [Abstract][Full Text] [Related]
8. Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India. Freedberg KA; Kumarasamy N; Borre ED; Ross EL; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP AIDS Res Hum Retroviruses; 2018 Jun; 34(6):486-497. PubMed ID: 29620932 [TBL] [Abstract][Full Text] [Related]
9. POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis. Vojnov L; Markby J; Boeke C; Harris L; Ford N; Peter T PLoS One; 2016; 11(5):e0155256. PubMed ID: 27175484 [TBL] [Abstract][Full Text] [Related]
10. How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa? Scott Braithwaite R; Nucifora KA; Toohey C; Kessler J; Uhler LM; Mentor SM; Keebler D; Hallett T AIDS; 2014 Jan; 28 Suppl 1(0 1):S73-83. PubMed ID: 24468949 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. Keebler D; Revill P; Braithwaite S; Phillips A; Blaser N; Borquez A; Cambiano V; Ciaranello A; Estill J; Gray R; Hill A; Keiser O; Kessler J; Menzies NA; Nucifora KA; Vizcaya LS; Walker S; Welte A; Easterbrook P; Doherty M; Hirnschall G; Hallett TB Lancet Glob Health; 2014 Jan; 2(1):e35-43. PubMed ID: 25104633 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Whole-Blood Alere Q NAT Point-of-Care RNA Assay for HIV-1 Viral Load Monitoring in a Primary Health Care Setting in Mozambique. Jani IV; Meggi B; Vubil A; Sitoe NE; Bhatt N; Tobaiwa O; Quevedo JI; Loquiha O; Lehe JD; Vojnov L; Peter TF J Clin Microbiol; 2016 Aug; 54(8):2104-8. PubMed ID: 27252459 [TBL] [Abstract][Full Text] [Related]
13. Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study. Dorward J; Garrett N; Quame-Amaglo J; Samsunder N; Ngobese H; Ngomane N; Moodley P; Mlisana K; Schaafsma T; Donnell D; Barnabas R; Naidoo K; Abdool Karim S; Celum C; Drain PK BMJ Open; 2017 Sep; 7(9):e017507. PubMed ID: 28963304 [TBL] [Abstract][Full Text] [Related]
14. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis. Ciaranello AL; Myer L; Kelly K; Christensen S; Daskilewicz K; Doherty K; Bekker LG; Hou T; Wood R; Francke JA; Wools-Kaloustian K; Freedberg KA; Walensky RP PLoS One; 2015; 10(3):e0117751. PubMed ID: 25756498 [TBL] [Abstract][Full Text] [Related]
15. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings. Bishai D; Colchero A; Durack DT AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710 [TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of monitoring strategies for antiretroviral therapy of HIV infected patients in resource-limited settings: software tool. Estill J; Salazar-Vizcaya L; Blaser N; Egger M; Keiser O PLoS One; 2015; 10(3):e0119299. PubMed ID: 25793531 [TBL] [Abstract][Full Text] [Related]
17. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Laurent C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Mbougua JB; Boyer S; Carrieri MP; Mben JM; Dontsop M; Kazé S; Molinari N; Bourgeois A; Mpoudi-Ngolé E; Spire B; Koulla-Shiro S; Delaporte E; Lancet Infect Dis; 2011 Nov; 11(11):825-33. PubMed ID: 21831714 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis. Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009 [TBL] [Abstract][Full Text] [Related]